CLINICAL_TRIALS
trial_result
· 2019-04-05
Clinical Trial Update: A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males [Phase 2]
Summary
Phase 2 trial update for setipiprant tablets in male androgenetic alopecia has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Alopecia | Phase 2 | Status: COMPLETED | Results posted: 2019-04-05